Mattingly is an associate professor and vice chair of research in the Department of Pharmacotherapy at the University of Utah ...

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in ...

The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...

The Federal Trade Commission (“FTC”) released its second interim report on Jan. 14, 2025, accusing pharmacy benefit managers (PBMs) of marking up the prices of specialty generic drugs. FTC’s report ...

CVS Caremark, Express Scripts and OptumRx dramatically mark up specialty generic drugs to affiliated pharmacies, the Federal ...

CVS Health’s PBM might influence which drugs are promoted and covered, potentially preferring Cordavis’ products over others. The result would stifle market competition. Patient steerage to ...

“PBM tactics inflate American’s prescription drug costs, force pharmacy closures, and block access to Americans’ pharmacies of choice. The work done by Congress in the 118th Congress and in ...

House Republicans have abandoned language to rein in the pharmacy benefit manager (PBM) industry from a new government funding bill released late Thursday. Leaders earlier this week agreed to PBM ...

which is the PBM’s specialty pharmacy. What CVS Caremark and Express Scripts are doing is (mostly) steering patients to their preferred products, which aren’t necessarily the least expensive.

Banning PBM spread pricing in Medicaid-managed care ... We sell different types of products and services to both investment professionals and individual investors. These products and services ...